{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:35:39Z","timestamp":1773160539574,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T00:00:00Z","timestamp":1376524800000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.virol.2012.04.019","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T14:02:48Z","timestamp":1337176968000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication"],"prefix":"10.1016","volume":"430","author":[{"given":"Jinhua","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James H.","family":"McLinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma L.","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirjal","family":"Bhattarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack T.","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.04.019_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/jvi.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells","volume":"59","author":"Adachi","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1537-2995.1997.37697335149.x","article-title":"G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus","volume":"37","author":"Alter","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.virol.2012.04.019_bib3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJM199703133361102","article-title":"The Incidence of Transfusion-Associated Hepatitis G Virus Infection and its relation to liver disease","volume":"336","author":"Alter","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199703133361101","article-title":"Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection","volume":"336","author":"Alter","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib5","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.72.1.868-872.1998","article-title":"Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins","volume":"72","author":"Belyaev","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00002030-200404090-00005","article-title":"GB Virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality","volume":"18","author":"Bjorkman","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/QAD.0b013e32823bc9b7","article-title":"Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART","volume":"21","author":"Bjorkman","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1096-9071(199609)50:1<97::AID-JMV16>3.0.CO;2-V","article-title":"Prevalence studies of GB virus-C using reverse-transcriptase-polymerase chain reaction","volume":"50","author":"Dawson","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib9","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/JVI.73.5.4052-4061.1999","article-title":"In vitro infection of human peripheral blood mononuclear cells by GB virus C\/Hepatitis G virus","volume":"73","author":"Fogeda","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0042-6822(03)00585-3","article-title":"Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures","volume":"316","author":"George","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.04.019_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/499435","article-title":"GB virus C replicates in primary T and B lymphocytes","volume":"193","author":"George","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<253::AID-JMV13>3.0.CO;2-F","article-title":"Antienvelope antibodies are protective against GBV-C reinfection: evidence from the liver transplant model","volume":"56","author":"Hassoba","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib13","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1021\/jm100452c","article-title":"Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection","volume":"53","author":"Herrera","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2012.04.019_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1423-0410.1998.7430161.x","article-title":"Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood","volume":"74","author":"Heuft","year":"1998","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.virol.2012.04.019_bib15","first-page":"25","article-title":"Prevalence, persistence and liver enzyme levels of HGV RNA-positive blood donors determined by large-scale screening and transmission by blood components","volume":"50","author":"Hitzler","year":"2004","journal-title":"Clin. Lab."},{"key":"10.1016\/j.virol.2012.04.019_bib16","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1097\/01.aids.0000180097.50393.df","article-title":"Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors","volume":"19","author":"Jung","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/QAD.0b013e32803277c7","article-title":"HIV entry inhibition by the envelope 2 glycoprotein of GB virus C","volume":"21","author":"Jung","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2893.1997.tb00208.x","article-title":"Molecular characterization of the hepatitis G virus","volume":"4","author":"Kim","year":"1997","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virol.2012.04.019_bib19","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1128\/JVI.02366-10","article-title":"Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition","volume":"85","author":"Koedel","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000762","article-title":"The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule","volume":"6","author":"Krey","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2012.04.019_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.abb.2005.06.027","article-title":"Characterization of a putatitve fusogenic sequence in the E2 hepatitis G protein","volume":"442","author":"Larios","year":"2005","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.virol.2012.04.019_bib22","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1128\/jvi.71.10.7804-7806.1997","article-title":"Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C virus and G virus","volume":"71","author":"Laskus","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1096-9071(199601)48:1<60::AID-JMV10>3.0.CO;2-A","article-title":"Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis","volume":"48","author":"Leary","year":"1996","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/314671","article-title":"Carriage of GB Virus C\/Hepatitis G Virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons","volume":"179","author":"Lefr\u00e8re","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of Flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.virol.2012.04.019_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.271.5248.505","article-title":"Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent","volume":"271","author":"Linnen","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virol.2012.04.019_bib27","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1097\/QAD.0b013e32832d7a11","article-title":"GBV-C infection modulates T cell activation in recently HIV-infected subjects and is independent of HIV-1 viral load","volume":"23","author":"Maidana Giret","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib28","doi-asserted-by":"crossref","first-page":"12131","DOI":"10.1128\/JVI.01206-06","article-title":"Characterization of an immunodominant antigenic site on GB virus C glycoprotein E2 that is involved in cell binding","volume":"80","author":"McLinden","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2893.2009.01194.x","article-title":"GB virus type C interactions with HIV: The role of envelope glycoproteins","volume":"16","author":"Mohr","year":"2009","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virol.2012.04.019_bib30","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.4049\/jimmunol.1001980","article-title":"GB Virus C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates","volume":"185","author":"Mohr","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.04.019_bib31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/00002030-200307040-00006","article-title":"Regulation of CC chemokine receptor 5 in Hepatitis G virus infection","volume":"17","author":"Nattermann","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2012.04.019_bib32","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hep.510270335","article-title":"Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic","volume":"27","author":"Pessoa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2012.04.019_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1006\/viro.1996.0602","article-title":"Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker","volume":"225","author":"Pilot-Matias","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.04.019_bib34","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s100960000352","article-title":"High prevalence of GB virus C\/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1","volume":"19","author":"Rey","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib35","unstructured":"Rydze, R.T., Bhattarai, N., Stapleton, J.T. GB virus C infection is associated with a reduced rate of reactivation of latent HIV and protection against activation-induced T cell death. Antivir Ther, In Press."},{"key":"10.1016\/j.virol.2012.04.019_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3851\/IMP1602","article-title":"GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells","volume":"15","author":"Schwarze-Zander","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virol.2012.04.019_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nm0695-564","article-title":"Isolation of novel virus-like sequences associated with human hepatitis","volume":"1","author":"Simons","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/j.virol.2012.04.019_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-2003-39943","article-title":"GB virus type C\/hepatitis G virus","volume":"23","author":"Stapleton","year":"2003","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: A Review and proposed classification of GBV-A, GBV-C(HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib40","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/hep.510260635","article-title":"Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors","volume":"26","author":"Tacke","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2012.04.019_bib41","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-125-9-199611010-00007","article-title":"Effect of hepatitis G virus infection on chronic hepatitis C","volume":"125","author":"Tanaka","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2893.1998.00095.x","article-title":"Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis","volume":"5","author":"Tanaka","year":"1998","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virol.2012.04.019_bib43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1086\/514245","article-title":"Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection","volume":"177","author":"Thomas","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib44","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.510280213","article-title":"Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection","volume":"28","author":"Tillmann","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2012.04.019_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMoa010398","article-title":"Infection with GB virus C and reduced mortality among HIV-infected patients","volume":"345","author":"Tillmann","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib46","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1086\/427559","article-title":"GB Virus C coinfection and HIV-1 disease progression: The Amsterdam cohort study","volume":"191","author":"Van der Bij","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.04.019_bib47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa030107","article-title":"Persistent GB virus C infection and survival in HIV-infected men","volume":"350","author":"Williams","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib48","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1128\/JVI.74.21.10055-10062.2000","article-title":"Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low density lipoprotein receptor","volume":"74","author":"Wunschmann","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib49","doi-asserted-by":"crossref","first-page":"9125","DOI":"10.1128\/JVI.74.19.9125-9133.2000","article-title":"Full-length GB Virus C (Hepatitis G Virus) RNA transcripts are infectious in primary CD4-Positive T cells","volume":"74","author":"Xiang","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.04.019_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa003364","article-title":"Effect of coinfection with GB Virus C (Hepatitis G virus) on survival among patients with HIV infection","volume":"345","author":"Xiang","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2012.04.019_bib51","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/S0140-6736(04)16453-2","article-title":"Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1a, MIP-1b, and SDF-1","volume":"363","author":"Xiang","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2012.04.019_bib52","doi-asserted-by":"crossref","first-page":"15570","DOI":"10.1073\/pnas.0604728103","article-title":"An 85 amino acid segment of the GB Virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T-cells","volume":"103","author":"Xiang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"e2580","key":"10.1016\/j.virol.2012.04.019_bib53","first-page":"1","article-title":"Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication","volume":"3","author":"Xiang","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2012.04.019_bib54","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.4049\/jimmunol.0902276","article-title":"Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells","volume":"183","author":"Xiang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.04.019_bib55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1468-1293.2006.00366.x","article-title":"Effect of early and late GBV-C viremia on survival of HIV infected individuals: A meta-analysis","volume":"7","author":"Zhang","year":"2006","journal-title":"HIV Med."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221200222X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268221200222X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:16:45Z","timestamp":1758586605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268221200222X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S004268221200222X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.04.019","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}